Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

March 24, 2017

Primary Completion Date

June 24, 2018

Study Completion Date

January 31, 2019

Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMedication Adherence
Interventions
BEHAVIORAL

Pharmaceutical care and adherence aids

Medication review including drug-interaction check, individual patient counseling to improve understanding of treatment rationale and to elicit and address treatment-related concerns, provision of information booklets and adherence aids (calender blister packaging and smartphone medication reminder application), phone calls and face-to-face visits to follow-up on medication-related issues scheduled over a period of 6 months.

Trial Locations (2)

50603

University Malaya Medical Centre, Kuala Lumpur

68000

Ampang hospital, Ampang

All Listed Sponsors
collaborator

University of Malaya

OTHER

collaborator

Ampang Hospital, Malaysia

UNKNOWN

lead

UCSI University

OTHER

NCT03090477 - Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients | Biotech Hunter | Biotech Hunter